FDA Inspection
Degowin Blood CenterDegowin Blood Center – FDA Inspection, Oct 24, 2012
Record Details
This FDA Inspection record concerns Degowin Blood Center, with an inspection on October 24, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Degowin Blood Center
- Inspection Date
- October 24, 2012
- Product Type
- Biologics
View Company Profile
ID · 1acdc010-c60c-4356-862d-468614546190
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 805206
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Degowin Blood Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 13, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 3, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Degowin Blood Center
- FDA Inspection 1259069 - 2024-12-12
- FDA Inspection 1094007 - 2019-06-06
- FDA Inspection 1001567 - 2017-02-15
- FDA Inspection 915232 - 2015-02-13
- FDA Inspection 696431 - 2010-11-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.